After stopping GLP-1 obesity drugs, people regain weight and lose the heart health benefits. Weight and heart risks return after stopping treatment with these drugs. Studies show that patients regain lost weight after stopping the medication. Heart health benefits, such as risk reduction, are also lost. GLP-1 medications help reduce weight and improve heart health while taking them. After they are discontinued, these effects disappear. The article highlights the risks associated with stopping treatment.